Company Overview and News

 
Domino's May Be The First To Fall Among Weakness In Restaurants

22h seekingalpha
Increasing leverage through debt issuance and buybacks exposes Domino's to a cyclical downturn in the restaurant business as same store sales growth already begins to slow.

 
Restaurant Brands Rides on Franchising Amid Competition

2018-05-21 zacks
Restaurant Brands International Inc. (QSR - Free Report) has been undertaking various sales-boosting initiatives that should continue to drive the company’s top line.

 
PepsiCo Is The Perfect 3G Target

2018-05-18 seekingalpha
3G has historically focused on branded consumer businesses with high market share and attractive product margins, but bloated cost structures.

 
Famous Dave's: Plenty Of Meat Left On The Bone

2018-05-18 seekingalpha
Asset-Light/Highly Recurring EBITDA Run Rate of $9 million. Peers Trade at a Mid-Teens Multiple on EBITDA.

 
Bill Ackman calls for a breakup of United Technologies - MarketWatch

2018-05-17 marketwatch
Billionaire hedge-fund manager Bill Ackman on Thursday called for a breakup of United Technologies Corp. saying the individual businesses are more likely to trade at fair value as independent companies.

 
Tracking Bill Ackman's Pershing Square Portfolio - Q1 2018 Update

2018-05-16 seekingalpha
The largest three 13F positions are Restaurant Brands International, Chipotle Mexican Grill, and Automatic Data Processing and together they account for around two-thirds of the portfolio.

6
Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q1 2018 Update

2018-05-16 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway’s (NYSE:BRK.A) (NYSE:BRK.B) 13F stock portfolio on a quarterly basis. It is based on Warren Buffett’s regulatory 13F Form filed on 05/15/2018. Please visit our Tracking 10 Years Of Berkshire Hathaway's Investment Portfolio article series for an idea on how his holdings have progressed over the years and our previous update for the moves in Q4 2017.

 
50 'Safer' Dividend Wall St. Favored Consumer Cyclical Stocks Topped By Entravision Gains Per May Targets

2018-05-16 seekingalpha
Latino Media firm, Entravision, beat out CSS Industries and Tegna combined net gains per analyst target-price estimates calculated 5/14/18.

 
Tim Hortons franchisee sues parent company for $4 million over licence renewal

2018-05-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Tim Hortons franchisee sues parent company for $4M over licence renewal

2018-05-15 cbc.ca
A Tim Hortons franchisee filed a $4-million lawsuit against the coffee and doughnut chain's parent company after he says it refused to renew a licence for one of his stores in bad faith.

 
Why Wendy’s Same-Store Sales Growth Failed to Meet Estimates

2018-05-10 marketrealist
Wendy’s (WEN) posted SSSG (same-store sales growth) of 1.8%, with company-owned restaurants posting SSSG of 0.8% and franchised restaurants posting 1.8%.

 
Wendy’s Stock Price Fell on Weak Same-Store Sales Growth

2018-05-10 marketrealist
Wendy’s (WEN) posted its 1Q18 earnings after the market closed on May 8. The company posted adjusted EPS (earnings per share) of $0.11 on revenues of $380.6 million. Compared to 1Q17, Wendy’s adjusted revenue increased 6.7%, while its adjusted EPS grew 22.2%.

 
What Drove Wendy’s Revenue in 1Q18?

2018-05-10 marketrealist
Wendy’s (WEN) posted revenue of $380.6 million in 1Q18, which represents a rise of 33.1% from $285.2 million in 1Q17. The company’s 1Q18 revenue outperformed analysts’ revenue estimate of $379.5 million.

 
Tim Hortons president is on cross-country tour to regain franchisees’ trust

2018-05-10 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Tim Hortons president vows to improve franchisee relations after unrest

2018-05-10 cbc.ca
President Alex Macedo has been crisscrossing the country over the last few days, meeting with thousands of franchisees in a bid to regain their trust and convince them that the fast food giant is committed to improving its strained relationship with some owners.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 76131D103